{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 2.8037355, "regularMarketPrice": 2.2, "exchange": "NMS", "shortName": "Atara Biotherapeutics, Inc.", "longName": "Atara Biotherapeutics, Inc.", "messageBoardId": "finmb_248196818", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 0.673, "fiftyDayAverage": 2.837, "fiftyDayAverageChange": -0.63699985, "fiftyDayAverageChangePercent": -0.22453292, "twoHundredDayAverage": 3.85325, "twoHundredDayAverageChange": -1.65325, "twoHundredDayAverageChangePercent": -0.4290534, "marketCap": 244747808, "forwardPE": -1.2021858, "priceToBook": 3.2689452, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.7 - Hold", "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1683576060, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.94, "epsForward": -1.83, "epsCurrentYear": -2.42, "priceEpsCurrentYear": -0.9090909, "sharesOutstanding": 97972200, "firstTradeDateMilliseconds": 1413466200000, "priceHint": 4, "regularMarketChange": 0.059999943, "regularMarketTime": 1684180804, "regularMarketDayHigh": 2.31, "regularMarketDayRange": "2.14 - 2.31", "regularMarketDayLow": 2.14, "regularMarketVolume": 1972917, "regularMarketPreviousClose": 2.14, "bid": 0.0, "ask": 0.0, "bidSize": 22, "askSize": 40, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 2.14, "averageDailyVolume3Month": 1381281, "averageDailyVolume10Day": 1916540, "fiftyTwoWeekLowChange": 0.10000014, "fiftyTwoWeekLowChangePercent": 0.04761912, "fiftyTwoWeekRange": "2.1 - 9.34", "fiftyTwoWeekHighChange": -7.1400003, "fiftyTwoWeekHighChangePercent": -0.764454, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 9.34, "marketState": "PRE", "displayName": "Atara Biotherapeutics", "symbol": "ATRA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2380 Conejo Spectrum Street", "address2": "Suite 200", "city": "Thousand Oaks", "state": "CA", "zip": "91320", "country": "United States", "phone": "805 623 4211", "website": "https://www.atarabio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA2271 and ATA3271 to treat mesothelin; and ATA3219 for the treatment of B-cell malignancies, as well as ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center. The company was incorporated in 2012 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 334, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pascal  Touchon D.V.M.", "age": 58, "title": "Pres, CEO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 1077856, "fmt": "1.08M", "longFmt": "1,077,856"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Charlene A. Banard", "age": 59, "title": "Exec. VP & Chief Technical Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 753089, "fmt": "753.09k", "longFmt": "753,089"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. K. Amar Murugan", "age": 46, "title": "Exec. VP & Chief Legal Officer", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 618524, "fmt": "618.52k", "longFmt": "618,524"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jakob  Dupont M.D.", "age": 57, "title": "Consultant", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 750530, "fmt": "750.53k", "longFmt": "750,530"}, "exercisedValue": {"raw": 64250, "fmt": "64.25k", "longFmt": "64,250"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric  Hyllengren", "age": 47, "title": "Sr. VP & CFO", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anhco  Nguyen", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Kerry Beth Daly", "title": "Head of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joseph  Newell", "age": 52, "title": "Exec. VP", "yearBorn": 1970, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Manher  Joshi", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jill  Henrich", "age": 59, "title": "Head of Global Regulatory Affairs", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}